This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Bionomics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8.5%.

Top 24 shareholders own 69.58% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
30.8%	Citigroup Inc.,Banking and Securities Investments	452,849,940	US$2.7m	7.05%	no data
12.6%	BVF Partners L.P.	184,664,665	US$1.1m	0%	0.03%
10.3%	Apeiron Investment Group	151,233,327	US$907.4k	0%	0.54%
7.44%	Presight Capital	109,311,660	US$655.9k	0%	13.95%
2.44%	Medical Strategy GmbH, Asset Management Arm	35,792,280	US$214.8k	0%	0.02%
1.54%	Point72 Asset Management, L.P.	22,680,000	US$136.1k	-1.56%	no data
0.67%	Woodline Partners LP	9,800,280	US$58.8k	-1.33%	no data
0.62%	Jason Camm	9,102,132	US$54.6k	0%	no data
0.6%	L & M Group Limited	8,884,085	US$53.3k	0%	no data
0.47%	Vision VII Management LLC	6,830,075	US$41.0k	0%	no data
0.34%	Qualvest Pty Limited	5,000,000	US$30.0k	0%	no data
0.34%	Charmed5 Pty Ltd	5,000,000	US$30.0k	0%	no data
0.33%	Ambria Capital, LLC	4,845,050	US$29.1k	0%	no data
0.3%	Provendore Pty Ltd	4,418,550	US$26.5k	0%	no data
0.3%	Welas Pty Ltd	4,403,719	US$26.4k	0%	no data
0.19%	Mark Potter	2,750,000	US$16.5k	0%	no data
0.19%	Rebecca Potter	2,750,000	US$16.5k	0%	no data
0.035%	Australian Super Pty Ltd	513,981	US$3.1k	0%	no data
0.025%	Errol De Souza	366,698	US$2.2k	0%	no data
0.018%	Peter Miles Davies	269,984	US$1.6k	0%	no data
0.017%	David Wilson	251,939	US$1.5k	0%	no data
0.0087%	Elizabeth Doolin	127,629	US$765.8	0%	no data
0.0068%	Alan Fisher	100,000	US$600.1	0%	no data
0.0048%	Adrian Hinton	70,000	US$420.4	0%	no data